secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardant Health, Inc. (GH)
CIK:        0001576280
Form:       8-K
Filed at:   2025-02-07T23:59:59+00:00
Accession:  0001193125-25-022242
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardant Health exchanges $659.3M of 0% 2027 notes for $600M of 1.25% 2031 notes; plans $45M buyback
--------------------------------------------------------------------------------

- Issues $600M of 1.25% Convertible Senior Notes due Feb 15, 2031, exchanging for $659.3M of 0% Convertible 2027 Notes.
- Initial conversion price of new notes ~$62.22/share, a 35% premium to Feb 6, 2025 closing price.
- After close (~Feb 14, 2025), $490.7M of 2027 Notes remain outstanding with unchanged terms.
- Intends to repurchase ~$45M of common stock from participants; exchange agent will buy ~$35M separately.
- New notes are unregistered, issued under Section 4(a)(2) and 3(a)(9) exemptions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576280/000119312525022242/0001193125-25-022242-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576280/000119312525022242/d931211d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-022242

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer